Related references
Note: Only part of the references are listed.Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study
Stuart H. Isaacson et al.
PARKINSONISM & RELATED DISORDERS (2019)
Efficacy and safety of rotigotine in elderly patients with Parkinson's disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials
Masahiro Nomoto et al.
JOURNAL OF NEUROLOGY (2018)
A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease
Dirk Woitalla et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in de-novo Parkinsonian subjects: a randomized controlled trial with 18-month follow-up
D. Ferrazzoli et al.
JOURNAL OF NEUROLOGY (2018)
Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
Zhen-Xin Zhang et al.
PARKINSONISM & RELATED DISORDERS (2017)
Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo controlled trial using an axial inertial sensor
Roongroj Bhidayasiri et al.
PARKINSONISM & RELATED DISORDERS (2017)
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
Olivier Rascol et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease
Robert A. Hauser et al.
BMC NEUROLOGY (2016)
The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
Peter A. LeWitt et al.
CLINICAL NEUROPHARMACOLOGY (2016)
Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease
Sun Ju Chung et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage
Nir Giladi et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study
Jong-Min Kim et al.
BMC NEUROLOGY (2015)
Pharmacokinetic Properties and Tolerability of Rotigotine Transdermal Patch After Repeated-Dose Application in Healthy Korean Volunteers
Bo-Hyung Kim et al.
CLINICAL THERAPEUTICS (2015)
Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study
Joern Peter Sieb et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial
A. Antonini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
Willi Cawello et al.
CLINICAL DRUG INVESTIGATION (2014)
Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
Masahiro Nomoto et al.
JOURNAL OF NEUROLOGY (2014)
Non-ergot dopamine agonist rotigotine as a promising therapeutic tool in atypical parkinsonism syndromes: A 24 months pilot observational open-label study
D. V. Moretti et al.
NEUROPHARMACOLOGY (2014)
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
Peter A. LeWitt et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease
Nir Giladi et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER
K. Ray Chaudhuri et al.
PARKINSONISM & RELATED DISORDERS (2013)
Outcomes From Switching From Rotigotine Patch to Alternate Therapies in Parkinson's Disease
Shilpa Chitnis et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2012)
Parkinson's Disease and Parkinsonism: Neuropathology
Dennis W. Dickson
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Christopher G. Goetz
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Limitations of current Parkinson's disease therapy
O Rascol et al.
ANNALS OF NEUROLOGY (2003)
Share Paper
